Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 15Breast Neoplasms 14Sarcoma 11Squamous Cell Carcinoma of Head and Neck 10Glioblastoma 10Esophageal Neoplasms 9Rectal Neoplasms 8Stomach Neoplasms 7Urinary Bladder Neoplasms 6Neoplasms 6Carcinoma, Hepatocellular 6Pancreatic Neoplasms 5Colorectal Neoplasms 5Brain Neoplasms 5Oropharyngeal Neoplasms 4Lung Neoplasms 4Hypopharyngeal Neoplasms 4Head and Neck Neoplasms 4Glioma 4Colonic Neoplasms 4Recurrence 3Prostatic Neoplasms 3Parkinson Disease 4, Autosomal Dominant Lewy Body 3Neoplasm Metastasis 3Mouth Neoplasms 3Melanoma 3Astrocytoma 3Triple Negative Breast Neoplasms 2Thyroid Neoplasms 2Skin Neoplasms 2

Interventions

Paclitaxel 2Cisplatin 2Carboplatin 2osimertinib 1cemiplimab 1Surgical Procedures, Operative 1Pemetrexed 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Resectable Non-small Cell Lung Cancer × Surgical Procedures, Operative × 1 year × Clear all
NCT07038460 2025-06-26

NEO-LISI

Guangdong Provincial People's Hospital

Phase 2 Not yet recruiting
134 enrolled
Thoracic

Resectable Non-small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡